First-in-Human PET/CT Imaging of FXX489, a Second-Generation Cyclic Peptide FAP Inhibitor: A Translational Exploratory Study
- DOI
- 10.1021/acs.molpharmaceut.6c00763
- Published
- 2026-09-25
- Container
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acs.molpharmaceut.6c00763,
title = {First-in-Human PET/CT Imaging of FXX489, a Second-Generation Cyclic Peptide FAP Inhibitor: A Translational Exploratory Study},
author = {Yi Tian and Leyi Ying and Yuxiang Wang and Shu Wang and Xuefei Li and Yaming Li and Xuena Li},
year = {2026},
journal = {Molecular Pharmaceutics},
doi = {10.1021/acs.molpharmaceut.6c00763},
url = {https://doi.org/10.1021/acs.molpharmaceut.6c00763}
}RIS
TY - JOUR TI - First-in-Human PET/CT Imaging of FXX489, a Second-Generation Cyclic Peptide FAP Inhibitor: A Translational Exploratory Study AU - Yi Tian AU - Leyi Ying AU - Yuxiang Wang AU - Shu Wang AU - Xuefei Li AU - Yaming Li AU - Xuena Li PY - 2026 JO - Molecular Pharmaceutics DO - 10.1021/acs.molpharmaceut.6c00763 UR - https://doi.org/10.1021/acs.molpharmaceut.6c00763 ER -
APA
Tian, Y., Ying, L., Wang, Y., Wang, S., Li, X., Li, Y., & Li, X. (2026). First-in-Human PET/CT Imaging of FXX489, a Second-Generation Cyclic Peptide FAP Inhibitor: A Translational Exploratory Study. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00763
Source records
- crossref · retrieved 2026-11-10T16:49:00.426Z